Showing results (1441-1450 of 1,613) with videos related to

Sort By:
Pageof 162
JAMA Oncology|February 4, 2021
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical TrialLaurence Klotz, Joseph Chin, Peter C Black, et al.
JAMA Oncology|July 9, 2017
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical TrialMohan Suntharalingam, Kathryn Winter, David Ilson, et al.
JAMA Oncology|July 9, 2017
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung CancerBailiang Li, Yi Cui, Maximilian Diehn, et al.
JAMA Oncology|August 22, 2018
Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysisGeorge B Hanna, Piers R Boshier, Sheraz R Markar, et al.
JAMA Oncology|August 22, 2018
Assessment of Safety and Immunogenicity of PVX-410 Vaccine With or Without Lenalidomide in Patients With Smoldering Multiple Myeloma: A Nonrandomized Clinical TrialAjay K Nooka, Michael Luhua Wang, Andrew J Yee, et al.
JAMA Oncology|May 1, 2018
Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and ResectionFahima Dossa, Sergio A Acuna, Aaron S Rickles, et al.
JAMA Oncology|July 29, 2018
Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine TumorsSimron Singh, Lesley Moody, David L Chan, et al.
JAMA Oncology|January 2, 2026
Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype: The Phase 3 MELATORCH Randomized Clinical TrialXinan Sheng, Gang Huang, Meiyu Fang, et al.
JAMA Oncology|August 21, 2017
Examining Bias in Studies of Statin Treatment and Survival in Patients With CancerLouise Emilsson, Xabier García-Albéniz, Roger W Logan, et al.
JAMA Oncology|October 20, 2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer, Ellen L Goode, Matthew S Block, et al.
Pageof 162